Useful Links :
Why Publish with us :
- » Open Access Policy
- » Flexible Online Submission
- » Preliminary Quality Report within 3 days
- » 21 days Rapid Peer-Review
- » High Quality Publication
- » Global Promotion
- » Responsive Editorial Staff
- » Globally Recognized Journals
- » 24/7 Editorial Office Availability
Advances in Hematology and Blood Disorders is a peer-reviewed, open-access Journal that mainly deals with the study of Hematology and blood research. It focuses on all aspects of hematology including blood cells, hematologic diseases, blood hemostatic mechanisms, hemato-oncology, immunology, and transfusion medicine. It also focuses on all aspects of the prevention and therapy of blood disorders.
The Journal publishes recent discoveries and current developments in the mode of original articles, review articles, case reports, short communications, editorials, etc. in all areas of the Hematology and Blood Research field.
We also welcome case reports from all areas of hematology including hematologic oncology, hemobiology, vascular biology, hemophilia, Blood and Marrow transplantation, Blood Transfusion, Blood Clots, Lymphatic System, Anemia, Platelet disorders, Eosinophilic disorders, Leukemia, Myeloma, Coagulation disorders, Autoimmune blood cell disorders, Blood cancers, Myeloproliferative neoplasms, Clinical platelet disorders, White blood cell disorders, etc.
Advances in Hematology and Blood Disorders aim to provide a standard global platform for high-quality research in the field of Hematology and Blood Research with a less turnaround time with the support of its eminent Editorial board members.
The Journal follows a single-blinded peer-review and the first decision on the submitted manuscripts will be sent to authors approximately in 18-21 days.